BEUDAMED
    115 results · 11ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Device × Classification: Eu Ivd General × Clear all

    Reaction Tube With Cap

    Device
    EU IVDD · Eu Ivd General ·Nantong EgensBiotechnology Co.,Ltd.·No longer on the market

    PC7 (770/488) SETUP KIT

    Device
    EU IVDD · Eu Ivd General ·Beckman Coulter Inc.·On the market·32 countries

    Blueprint Genetics CES Platform – Variant Seq

    Device
    EU IVDD · Eu Ivd General ·Blueprint Genetics Oy·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR B AND T-CELL SUBTYPING

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market

    ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)

    Device
    EU IVDD · Eu Ivd General ·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market